Journal of Viral Hepatitis

Articles Available on Medscape

• Efficacy and Safety of Alfosbuvir Plus Daclatasvir in Chinese Patients With Hepatitis C Virus Genotypes 1, 2, 3, and 6 Infection
  This study investigated the efficacy and safety of oral alfosbuvir 400, 600 or 800 mg daily combined with 60 mg daily of daclatasvir for the treatment of HCV infection.

  August 09, 2022

• Determining the Lower Limit of Detection Required for HCV Viral Load Assay for Test of Cure Following Direct-acting Antiviral-based Treatment Regimens
  This study assessed the distribution of detectable viral loads 12 weeks following the end of treatment for HCV infection to inform the lower limit of detection of viral load assays for test of cure.

  August 02, 2022

• Soluble Inflammatory Mediators Identify HCV Patients Who May Be Cured With Four Weeks of Antiviral Treatment
  Are soluble inflammatory mediators useful as biomarkers for prediction of a successful ultrashort antiviral treatment regimen for chronic HCV?

  July 26, 2022

• VirA+EmiC Project: Evaluating Real-world Effectiveness and Sustainability of Integrated Routine Opportunistic Hepatitis B and C Testing in a Large Urban Emergency Department
  This study evaluated the real-world sustainability of an emergency department opt-out HCV and HBV testing program. Is opt-out ED testing practical in a large urban hospital setting?

  July 19, 2022

• Efficacy of Hepatitis C Virus Eradication After Curative Treatment for Hepatocellular Carcinoma in Patients With Advanced Hepatocellular Carcinoma and Decreased Hepatic Functional Reserve
  Does DAA therapy after hepatocellular carcinoma treatment benefit patients with advanced-stage HCC or HCC with decompensated cirrhosis?

  July 12, 2022

Table of Contents

2021 -

• The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: data from the ICONA Foundation Cohort. 

  February 18, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Reduction in hepatitis C-related hospitalisations after the implementation of the Strategic Plan for Tackling Hepatitis C in the Spanish National Health System: regional level differences. 

  February 18, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Analytical validation of hepatitis B core-related antigen (HBcrAg) using dried blood spots (DBS). 

  February 17, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Hepatitis C treatment in a co-located mental health and alcohol and drug service using a nurse-led model of care. 

  February 17, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Clinical effects of NTCP-inhibitor myrcludex B. 

  February 17, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass. 

  February 15, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy. 

  February 15, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Validation of the HCC-RESCUE Score to Predict Hepatocellular Carcinoma Risk in Caucasian Chronic Hepatitis B Patients Under Entecavir or Tenofovir Therapy. 

  February 15, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Impact of direct acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis C: systematic review and meta-analysis. 

  February 08, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Benefit of transaminase elevations in establishing functional cure of HBV infection during NAP-based combination therapy. 

  February 08, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents. 

  February 08, 2021

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren's syndrome: 15-year analysis of the national database of Taiwan. 

  February 06, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Viral hepatitis C pandemic: challenges and threats to its elimination. 

  February 06, 2021

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group. 

  February 03, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection. 

  February 01, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment. 

  January 23, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Entecavir-induced interferon-λ1 suppresses type 2 innate lymphoid cells in patients with hepatitis B virus-related liver cirrhosis. 

  January 22, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival. 

  January 22, 2021

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• Why do patients with chronic hepatitis C drink alcohol? An examination of pain, depression and drinking motives. 

  January 21, 2021

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• Reply to: 'Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action'. 

  January 18, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta-analysis. 

  January 17, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Impact of maternal infection with hepatitis B virus on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology treatment: A population-based study. 

  January 16, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis. 

  January 16, 2021

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• The 48-week safety and therapeutic effects of tenofovir alafenamide in hbv-related acute-on-chronic liver failure: A prospective cohort study. 

  January 10, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Evaluation of seven rapid diagnostic tests for detection of hepatitis C virus antibodies in China. 

  January 09, 2021

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• Risk factors for difficult-to-treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub-Saharan Africa. 

  January 09, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project. 

  January 09, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed. 

  January 01, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]